Vaccines are complex laboratory creations designed for one seemingly simple purpose: to stimulate a theoretically protective immune response. However, some vaccines are not as likely to have their intended effect without an “adjuvant” to amplify the vaccinated individual’s response. Aluminum salts are the most common type of vaccine adjuvant in use, despite abundant science establishing aluminum as a neurotoxin.
In 2002, only two childhood vaccines contained aluminum adjuvants, but the aluminum picture had changed dramatically by 2016, when children received five aluminum-containing vaccines from birth to age three and at least two more in the teenage years. Two independent researchers are raising important questions about the wisdom of this ramped-up use of injected aluminum in young children. In a study published in the Journal of Trace Elements in Medicine and Biology (JTEMB) and a related online article, the researchers methodically show that current levels of aluminum in vaccines—wrongly termed “safe” by the Food and Drug Administration (FDA)—derive from “outdated information, unwarranted assumptions and errors.”
…the levels of aluminum currently present in individual vaccines and in the modern vaccine schedule as a whole are “problematically high.”